SCHEMBL8912378

SCHEMBL8912378

CCCN(C(=O)OCC(C)C)C1Cc2ccc(C3=NNC(=O)CC3)cc2C1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
NPY1R P25929 1/20 0.40
NPY2R P49146 1/20 0.40
PDE3B Q13370 12/20 0.39
PDE3A Q14432 12/20 0.39
PDE4B Q07343 7/20 0.39
PDE4A P27815 6/20 0.39
PDE4C Q08493 6/20 0.39
PDE4D Q08499 6/20 0.39
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8914459 0.88 PDE3B (0.45) MAPTKMT2ALMNANPY1RNPY2R
SCHEMBL8911969 0.86 PDE3B (0.40) MAPTKMT2ALMNANPY1RNPY2R
SCHEMBL8912302 0.83 MAPT (0.42) MAPTKMT2ALMNANPY1RNPY2R
SCHEMBL8911929 0.79 PDE4A (0.36) MAPTKMT2ALMNAPDE3BPDE3A
SCHEMBL8911889 0.70 CA12 (0.51) MAPTKMT2ALMNANPY1RNPY2R
SCHEMBL8303551 0.70 LMNA (0.48) MAPTLMNANPY1RNPY2RPDE3B
SCHEMBL8912023 0.70 CA12 (0.49) MAPTKMT2ALMNANPY1RNPY2R
SCHEMBL8300078 0.70 MAPT (0.46) MAPTKMT2ALMNANPY1RNPY2R
SCHEMBL8911629 0.69 MAPT (0.42) MAPTKMT2ALMNANPY1RNPY2R
SCHEMBL8911986 0.69 MAPT (0.42) MAPTKMT2ALMNANPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5605901-A THERAPY FOR GRAM-NEGATIVE BACTERIA, NEPHRITIS TANABE SEIYAKU CO., LTD. (JP) 1997-02-25 US claimed
EP-0661274-A1 Indane derivatives, processes for preparing the same and synthetic intermediate of the same TANABE SEIYAKU CO., LTD. (JP) 1995-07-05 EP claimed
US-5605901-A THERAPY FOR GRAM-NEGATIVE BACTERIA, NEPHRITIS TANABE SEIYAKU CO., LTD. (JP) 1997-02-25 US disclosed
EP-0661274-A1 Indane derivatives, processes for preparing the same and synthetic intermediate of the same TANABE SEIYAKU CO., LTD. (JP) 1995-07-05 EP disclosed